Leading medical organizations team up to bring new TB treatments to those in need
03/19/2015. International organizations Partners In Health (PIH), Médecins Sans Frontières (MSF), Interactive Research and Development (IRD) and their financial partner UNITAID will start in April the endTB project, a partnership aimed at radically changing the management of multidrug-resistant tuberculosis (MDR-TB).
By 2019, endTB will provide access to two new anti-TB drugs (bedaquiline and delamanid), for 2,600 MDR-TB patients in 16 countries. These are the first new anti-TB drugs developed in over 50 years and these drugs offer new hope to patients suffering from MDR-TB.
Read the article on MSF website
Related Articles
INTERVIEW: UN humanitarian chief Stephen O’Brien
09/21/2015. “At the end of the day, every life saved is an achievement in itself.”
Partnering with the private sector to innovate humanitarian response
09/26/2018. Private sector actors can play a major role given their unique expertise, capacities, resources, and networks.
Countries in crisis: rethinking the role of development aid
02/23/2016. On the occasion of the 3rd National Conference Humanitarian the CEO of the French Development Agency invites us to consider development aid as an investment.
